NervGen Pharma Corp. (NGEN)
3.75
-0.10
(-2.60%)
USD |
NASDAQ |
May 08, 16:00
3.745
0.00 (0.00%)
After-Hours: 20:00
NervGen Pharma EPS Diluted (Quarterly) : -0.251 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0115 |
| Lexaria Bioscience Corp. | -0.0593 |
| InMed Pharmaceuticals, Inc. | -0.7327 |
| Target Group, Inc. (Canada) | -0.0009 |
| Tilray Brands, Inc. | -0.2358 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.30M |
| Total Expenses (Quarterly) | 19.30M |
| Enterprise Value | 287.39M |
| Earnings Yield | -11.27% |
| Normalized Earnings Yield | -7.973 |